Boston Scientific Corporation

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:07 2024-05-03 pm EDT			5-day change	1st Jan Change
72.86 ^USD	+1.15%		-0.42%	+26.03%

May. 02	Boston Scientific Insider Sold Shares Worth $1,257,488, According to a Recent SEC Filing	MT
May. 02	Boston Scientific Insider Sold Shares Worth $499,075, According to a Recent SEC Filing	MT

Boston Scientific Corporation Announces Impairment Results for the Three Months Ended September 30, 2022

October 26, 2022 at 06:39 am EDT

Boston Scientific Corporation announced impairment results for the three months ended September 30, 2022. For the quarter, the company reported Intangible asset impairment charges of $125 million against $128 million a year ago.

Latest news about Boston Scientific Corporation

Boston Scientific Insider Sold Shares Worth $1,257,488, According to a Recent SEC Filing	May. 02	MT
Boston Scientific Insider Sold Shares Worth $499,075, According to a Recent SEC Filing	May. 02	MT
Boston Scientific Insider Sold Shares Worth $719,562, According to a Recent SEC Filing	Apr. 29	MT
Daiwa Adjusts Price Target on Boston Scientific to $81 From $73	Apr. 26	MT
Redburn Atlantic Adjusts Price Target on Boston Scientific to $79 From $75	Apr. 26	MT
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength	Apr. 25	RE
UBS Raises Boston Scientific's Price Target to $90 From $74, Maintains Buy Rating	Apr. 25	MT
Oppenheimer Adjusts Boston Scientific's Price Target to $77 From $68	Apr. 25	MT
Bernstein Adjusts Boston Scientific Price Target to $86 From $75	Apr. 25	MT
Deutsche Bank Adjusts Price Target on Boston Scientific to $73 From $63	Apr. 25	MT
Baird Adjusts Price Target on Boston Scientific to $84 From $79	Apr. 25	MT
JPMorgan Adjusts Price Target on Boston Scientific to $82 From $72	Apr. 25	MT
Raymond James Adjusts Boston Scientific Price Target to $85 From $73	Apr. 25	MT
Wolfe Research Adjusts Boston Scientific Price Target to $81 From $72	Apr. 25	MT
CL King Adjusts Boston Scientific's Price Target to $82 From $72	Apr. 25	MT
Canaccord Genuity Adjusts Price Target on Boston Scientific to $83 From $81	Apr. 25	MT
Barclays Adjusts Boston Scientific's Price Target to $78 From $70	Apr. 25	MT
Wells Fargo Adjusts Price Target on Boston Scientific to $82 From $72	Apr. 25	MT
Truist Raises Price Target on Boston Scientific to $86 From $79, Keeps Buy Rating	Apr. 25	MT
Needham Adjusts Price Target on Boston Scientific to $82 From $71	Apr. 25	MT
RBC Capital Adjusts Price Target on Boston Scientific to $82 From $78	Apr. 25	MT
Mizuho Adjusts Price Target on Boston Scientific to $85 From $80	Apr. 25	MT
Health Care Down Amid Mixed Earnings -- Health Care Roundup	Apr. 24	DJ
Wall St edges lower as rising yields overshadow upbeat corporate results	Apr. 24	RE
BTIG Raises Boston Scientific's Price Target to $80 From $74	Apr. 24	MT

Chart Boston Scientific Corporation

Duration

Period

More charts

Company Profile

Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-14 - Bank of America's 2024 Health Care Conference

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Boston Scientific Corporation

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

72.85 USD

Average target price

81 USD

Spread / Average Target

+11.18%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
BOSTON SCIENTIFIC CORPORATION	+26.03%	106B
THERMO FISHER SCIENTIFIC	+7.84%	218B
DANAHER CORPORATION	+7.35%	183B
INTUITIVE SURGICAL, INC.	+13.04%	134B
SIEMENS HEALTHINEERS AG	-1.33%	61.12B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.81%	50.89B
AGILENT TECHNOLOGIES, INC.	+0.30%	40.3B
GE HEALTHCARE TECHNOLOGIES INC.	+2.78%	35.53B
RESMED, INC.	+26.14%	32.05B
PHILIPS NV	+18.76%	24.21B

Other Advanced Medical Equipment & Technology